Citation Impact
Citing Papers
β-Arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2
2009 StandoutNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Genomic and proteomic profiling I: Leiomyomas in African Americans and Caucasians
2007 Standout
Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1
2001
The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.
2011
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Oxygen-regulated transcription factors and their role in pulmonary disease
2000 StandoutNobel
G Protein-coupled Receptor Kinase and β-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics
2006 StandoutNobel
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
LPS induction of gene expression in human monocytes
2001 Standout
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Pathways of Egr-1-Mediated Gene Transcription in Vascular Biology
1999
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Serum response factor: toggling between disparate programs of gene expression
2003
Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
2015
Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy
2012
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
2007 StandoutNobel
Lymphangiogenesis in development and human disease
2005 StandoutNature
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
The pathobiology of mucositis
2004 Standout
High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosis
2000
Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II Receptor
2000
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Endothelial Cell Gene Regulation
2005
Angiotensin II-induced Transcriptional Activation of the Cyclin D1 Gene Is Mediated by Egr-1 in CHO-AT1A Cells
2001
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Klotho converts canonical FGF receptor into a specific receptor for FGF23
2006 StandoutNature
Transcription of the platelet-derived growth factor A-chain gene
2003
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
2007 StandoutNobel
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
2013
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
2002 Standout
Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
2004 StandoutNobel
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Macrophage activation and polarization
2007 Standout
β-arrestin-mediated receptor trafficking and signal transduction
2011 StandoutNobel
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy
2015
Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration
2000
Molecular Biology and Pathology of Lymphangiogenesis
2008 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Role of cyclic GMP in gene regulation
2005
O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
2004 StandoutNobel
Receptor regulation: β-arrestin moves up a notch
2005 StandoutNobel
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study
2018
Workshop: Mechanisms and Cardiovascular Damage in Hypertension
2001
Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy
2012
β-Arrestins and Cell Signaling
2007 StandoutNobel
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Angiotensin II–Stimulated Signaling Through G Proteins and β-Arrestin
2005 StandoutNobel
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Seven-Transmembrane Receptor Signaling Through β-Arrestin
2005 StandoutNobel
Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor
2000
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression
2001
Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity
2016 Standout
Thrombin and Phenotypic Modulation of the Endothelium
2003
Lipopolysaccharide Endotoxins
2002 Standout
Receptor regulation: β-arrestin moves up a notch
2005 StandoutNobel
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1
2000
Works of Fiona Day being referenced
Early Growth Response Factor-1 Induction by Injury Is Triggered by Release and Paracrine Activation by Fibroblast Growth Factor-2
1999
Angiotensin II (ATII)-inducible Platelet-derived Growth Factor A-chain Gene Expression Is p42/44 Extracellular Signal-regulated Kinase-1/2 and Egr-1-dependent and Mediated via the ATII Type 1 but Not Type 2 Receptor
1999
Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid Tumors
2011
Current Hepatitis B Screening Practices and Clinical Experience of Reactivation in Patients Undergoing Chemotherapy for Solid Tumors: A Nationwide Survey of Medical Oncologists
2011